Lexeo Therapeutics Signs Series Of Strategic Transactions To Expand Presence In Friedreich Ataxia
(RTTNews) - Lexeo Therapeutics, Inc. (LXEO), a clinical stage company, announced Tuesday a series of strategic transactions to expand its presence in Friedreich ataxia (FA), including the signing of a definitive agreement to acquire private clinical stage company Mantle Therapeut